Pediatric reference data of serum lipids and prevalence of dyslipidemia: Results from a population-based cohort in Germany

Clinical Biochemistry

Volumn 49, Issue 10-11, 2016, Pages 740-749

  Dathan Stumpf, Anne ^a   Vogel, Mandy ^a   Hiemisch, Andreas ^a   Thiery, Joachim ^a   Burkhardt, Ralph ^a   Kratzsch, Jürgen ^a   Kiess, Wieland ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

ApoA1; ApoB; HDL; LDL; LIFE Child; Prevalence dyslipidemia; Reference intervals; Serum lipids; Total cholesterol; Triglycerides

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; BIOLOGICAL MARKER; LIPID;

ADOLESCENT; ANALYTIC METHOD; ANTHROPOMETRIC PARAMETERS; ARTICLE; CHILD; CONCENTRATION PROCESS; CONTROLLED STUDY; DYSLIPIDEMIA; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GERMANY; HUMAN; HYPERTRIGLYCERIDEMIA; INFANT; LABORATORY TEST; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PEDIATRICS; PREVALENCE; PRIORITY JOURNAL; REFERENCE VALUE; SEX DIFFERENCE; VENOUS BLOOD; ANTHROPOMETRY; BLOOD; DYSLIPIDEMIAS; FOLLOW UP; LONGITUDINAL STUDY; NEWBORN; PRESCHOOL CHILD; PROGNOSIS; RISK FACTOR;

ADOLESCENT; ANTHROPOMETRY; BIOMARKERS; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DYSLIPIDEMIAS; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; INFANT; INFANT, NEWBORN; LIPIDS; LONGITUDINAL STUDIES; MALE; PREVALENCE; PROGNOSIS; REFERENCE VALUES; RISK FACTORS; TRIGLYCERIDES;

EID: 84960156600     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2016.02.010     Document Type: Article

References (37)

1. [1] Martins, Mdo C., Lima, Faleiro L., Fonseca, A., et al. Relationship between leptin and body mass and metabolic syndrome in an adult population. Rev. Port. Cardiol. 31 (2012), 711–719.
2. [2] National Heart, Lung, and Blood Institute (NHLBI), Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 128:Suppl. 5 (2011), 213–256.
3. [3] Juonala, M., Viikari, J.S., Kähönen, M., et al. Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: the cardiovascular risk in young Finns study. J. Am. Coll. Cardiol. 52 (2008), 293–299.
4. [4] Asayama, K., Hayashibe, H., Dobashi, K., et al. Increased serum cholesteryl ester transfer protein in obese children. Obes. Res. 10 (2002), 439–446.
5. [5] Benson, M., Hossain, J., Caulfield, M.P., et al. Lipoprotein subfractions by ion mobility in lean and obese children. J. Pediatr., 161, 2012 (997–100).
6. [6] Kojima, M., Kanno, H., Yamazaki, Y., et al. Association of low-density lipoprotein particle size distribution and cardiovascular risk factors in children. Acta Paediatr. 94 (2005), 281–286.
7. [7] Narverud, I., Halvorsen, B., Nenseter, M.S., et al. Oxidized LDL level is related to gene expression of tumour necrosis factor super family members in children and young adults with familial hypercholesterolaemia. J. Intern. Med. 273 (2013), 69–78.
8. [8] Leiviskä, J., Sundvall, J., Jauhiainen, M., et al. Apolipoprotein A-I and B in laboratory diagnostics of dyslipidemia-what benefits do we gain compared with cholesterol measurements?. Duodecim 130:22–23 (2014), 2331–2337.
9. [9] Kim, M.K., Ahn, C.W., Kang, S., et al. Association between Apolipoprotein B/Apolipoprotein A-1 and arterial stiffness in metabolic syndrome. Clin. Chim. Acta 437 (2014), 115–119.
10. [10] Robert-Koch-Institut (ed), Bevölkerungsbezogene Verteilungswerte ausgewählter Laborparameter aus der Studie zur Gesundheit von Kindern und Jugendlichen in Deutschland (KiGGS). Beiträge zur Gesundheitsberichterstattung des Bundes, [20], Robert-Koch-Inst., Berlin, 2009, ISBN: 978-3-89606-193-5.
11. [11] Can, M., Piskin, E., Guven, B., et al. Evaluation of serum lipid levels in children. Pediatr. Cardiol. 34:3 (2013), 566–569.
12. [12] Quante, M., Hesse, M., Döhnert, M., et al. The LIFE Child study: a life course approach to disease and health. BMC Public Health, 12, 2012, 1021.
13. [13] Vogel M., Kirsten T., Kratzsch J. et al., A new approach estimating reference values using unbalanced longitudinal data, unpublished results.
14. [14] R Core Team R, A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria., 2014 (URL http://www.R-project.org/).
15. [15] Cole, T.J., Green, P.J., Smoothing reference centile curves: the LMS method and penalized likelihood. Stat. Med. 11 (1992), 1305–1319.
16. [16] Cole, T.J., Stanojevic, S., Stocks, J., et al. Age- and size-related reference ranges: a case study of spirometry through childhood and adulthood. Stat. Med. 28 (2009), 880–898.
17. [17] Rigby, R.A., Stasinopoulos, D.M., Generalized additive models for location, scale and shape (with discussion). Appl. Stat. 54:part 3 (2005), 507–554.
18. [18] van Buuren, S., Fredriks, M., Worm plot: a simple diagnostic device for modelling growth reference curves. Stat. Med. 20 (2001), 1259–1277.
19. [19] McClatchey, K.D., Clinical Laboratory Medicine. second ed., 2002, Lippincott Williams & Wilkins, 107 (ISBN-13: 978-0683307511).
20. [20] Reed, A.H., Henry, R.J., Mason, W.B., Influence of statistical method used on the resulting estimate of normal range. Clin. Chem. 17 (1971), 275–284.
21. [21] Clinical and Laboratory Standards Institute (CLSI), Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline—third edition CLSI document C28-A3. http://shop.clsi.org/c.1253739/site/Sample_pdf/EP28A3C_sample.pdf, 2008.
22. [22] Slhessarenko, N., Jacob, C.M., et al. Serum lipids in Brazilian children and adolescents: determining their reference intervals. BMC Public Health, 15, 2015, 18.
23. [23] Tamimi, W., Albanyan, E., et al. Age- and gender-specific reference intervals for fasting blood glucose and lipid levels in school children measured with Abbott Architect c8000 Chemistry Analyzer. Indian J. Clin. Biochem. 27:2 (2012), 141–146.
24. [24] Colantonio, D.A., Kyriakopoulou, L., et al. Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children. Clin. Chem. 58:5 (2012), 854–868.
25. [25] Soldin, O.P., Bierbower, L.H., et al. Serum iron, ferritin, transferrin, total iron binding capacity, hs-CRP, LDL cholesterol and magnesium in children; new reference intervals using the Dade Dimension Clinical Chemistry System. Clin. Chim. Acta 342:1–2 (2004), 211–217.
26. [26] Mellerio, H., Alberti, C., et al. Novel modeling of reference values of cardiovascular risk factors in children aged 7 to 20 years. Pediatrics 129:4 (2012), e1020–e1029.
27. [27] Chan, M.K., Seiden-Long, I., et al. Canadian Laboratory Initiative on Pediatric Reference Interval Database (CALIPER): pediatric reference intervals for an integrated clinical chemistry and immunoassay analyzer, Abbott ARCHITECT ci8200. Clin. Biochem. 42 (2009), 885–891.
28. [28] Kulasingam, V., Jung, B.P., et al. Pediatric reference intervals for 28 chemistries and immunoassays on the Roche cobas® 6000 analyzer—a CALIPER pilot study. Clin. Biochem. 43:13–14 (2010), 1045–1050.
29. [29] Chourdakis, M., Buderus, S., et al. S2k-Leitlinien zur Diagnostik und Therapie von Hyperlipidämien bei Kindern und Jugendlichen, Aktualisierte Fassung. 2014 (guidelines under development).
30. [30] de Ferranti, S.D., Newburger, J.W., et al. Dyslipidemia in Children: Definition, Screening and Diagnosis. http://www.uptodate.com/contents/dyslipidemia-in-children-definition-screening-and-diagnosis, 2015.
31. [31] Klose, G., Laufs, U., et al. Familiäre Hypercholesterinämie: Entwicklungen in Diagnostik und Behandlung. Dtsch. Arztebl. Int. 111:31–32 (2014), 523–529.
32. [32] de Ferranti, S.D., Familial hypercholesterolemia in children and adolescents: a clinical perspective. J. Clin. Lipidol. 9:5 Suppl. (2015), 11–19.
33. [33] Benn, M., Watts, G.F., et al. Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J. Clin. Endocrinol. Metab. 97:11 (2012), 3956–3964.
34. [34] Ding, W., Dong, H., Mi, J., Prevalence of dyslipidemia in Chinese children and adolescents: a meta-analysis. Zhonghua Liu Xing Bing Xue Za. Zhi. 36:1 (2015), 71–77.
35. [35] Dathan-Stumpf, A., Vogel, M., Rieger, K., et al. Serum Lipid Levels are Related to Sociodemographic Characteristics: Results From a Population-based Childhood Cohort in Germany (LIFE-Child), Acta Paediatrica, In Revision. 2016.
36. [36] de Koning, L., Denhoff, E., et al. Associations of total and abdominal adiposity with risk marker patterns in children at high-risk for cardiovascular disease. BMC Obes., 2, 2015, 15.
37. [37] Kurth, B.M., Schaffrath, Rosario A., Die Verbreitung von Übergewicht und Adipositas bei Kindern und Jugendlichen in Deutschland, Ergebnisse des bundesweiten Kinder- und Jugendgesundheitssurveys (KiGGS). Bundesgesundheitsbl - Gesundheitsforsch -Gesundheitsschutz 50 (2007), 736–743 ( http://edoc.rki.de/oa/articles/reryPJPcmUGw/PDF/20pyWvIPNYV52.pdf).